Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tubal Carcinoma”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableStudy completedNCT06599749
What this trial is testing

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)

Who this might be right for
Adenocarcinoma of OvaryAdenocarcinoma, TubularPeritoneal Cancer
University Hospital, Basel, Switzerland 80
Early research (Phase 1)Study completedNCT00003967
What this trial is testing

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)Study completedNCT00157573
What this trial is testing

GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube Cancer
Massachusetts General Hospital 72
Testing effectiveness (Phase 2)Study completedNCT02022917
What this trial is testing

Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Chang Gung Memorial Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00003334
What this trial is testing

Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
NYU Langone Health
Early research (Phase 1)Study completedNCT00352300
What this trial is testing

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

Who this might be right for
Fallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more
Gynecologic Oncology Group 43
Not applicableEnded earlyNCT03922776
What this trial is testing

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer Stage IIICFallopian Tube Cancer Stage IIICFallopian Tube Cancer Stage IV+1 more
Centre Oscar Lambret 36
Testing effectiveness (Phase 2)UnknownNCT04620954
What this trial is testing

Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 31
Not applicableStudy completedNCT02221076
What this trial is testing

Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.

Who this might be right for
Cervix CancerEndometrium CancerOvarian Cancer+1 more
Mauna Kea Technologies 16
Not applicableNot Yet RecruitingNCT06393543
What this trial is testing

International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis

Who this might be right for
BRCA MutationSerous Tubal Intraepithelial CarcinomaOvarian Carcinoma+1 more
Radboud University Medical Center 600
Not applicableStudy completedNCT02281487
What this trial is testing

Hysterectomy for Benign Gynaecological Conditions With or Without Tubectomy

Who this might be right for
Abdominal Hysterectomy (& Wertheim)
Gynaecologisch Oncologisch Centrum Zuid 105
Testing effectiveness (Phase 2)Ended earlyNCT03100006
What this trial is testing

Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 13
Early research (Phase 1)Study completedNCT00003385
What this trial is testing

Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 48
Not applicableStudy completedNCT02518256
What this trial is testing

Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity

Who this might be right for
Ovarian Epithelial Cancer
Medical University of Vienna 270
Not applicableStudy completedNCT02062697
What this trial is testing

Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.

Who this might be right for
Ovarian Epithelial Cancer
Medical University of Vienna 50
Large-scale testing (Phase 3)Ended earlyNCT00050375
What this trial is testing

Clinical Trial for Ovarian Cancer (OvaRex®)

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 354
Testing effectiveness (Phase 2)UnknownNCT01180504
What this trial is testing

Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerTubal CarcinomaPrimary Peritoneal Carcinoma
University Hospital Heidelberg 36
Testing effectiveness (Phase 2)Study completedNCT00004060
What this trial is testing

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Daiichi Sankyo
Early research (Phase 1)Study completedNCT00437502
What this trial is testing

A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian, Tubal or Peritoneal Cancer
Michael Morse, MD 8
Testing effectiveness (Phase 2)UnknownNCT00003634
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AltaRex 400
Load More Results